Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer

You may be eligible if

• 1. ≥18，Lung Cancer Confirmed by Histopathology
• 2. Treated with Chemotherapy with or Without Checkpoint Inhibitors.
• 3. ECOG 0 - 1.
• 4. Predicted survival ≥ 12 weeks.
• 5. Adequate bone marrow hematopoiesis and organ function
• 6. Presence of measurable lesions according to RECIST 1.1.
• 7. Subjects with stable brain metastases may be included in the study.